Trials / Unknown
UnknownNCT04686942
Sonazoid-enhanced Ultrasound for the Detection of Colorectal Liver Metastases Less Than 2 cm
Evaluation of Contrast Sonazoid-enhanced Ultrasound for the Detection of Colorectal Liver Metastases Less Than 2 cm
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 550 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Preoperative chemotherapy is often used for patients with colorectal cancer liver metastasis (CLM). Many small CLMs (\<=2cm) may disappear after chemotherapy, while most of these are still alive. Ultrasonography (US) is a common imaging modality for the intraoperative detection tumor. Sonazoid is new echo-contrast agent, which is more stable and sensitive for detecting of small tumor. Investigators initially this prospective study to compare the detection performance before and after using sonazoid.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | After sonazoid | 0.015ml/mg sonazoid enhanced US to detection of liver metastases. |
Timeline
- Start date
- 2020-12-17
- Primary completion
- 2022-12-30
- Completion
- 2023-12-30
- First posted
- 2020-12-29
- Last updated
- 2020-12-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04686942. Inclusion in this directory is not an endorsement.